Healthcare - Biotechnology - NASDAQ - US
$ 0.803
-4.02 %
$ 3.45 M
Market Cap
-0.05
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
55.96%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Revelation Biosciences, Inc.
REVB has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart REVB
EBIT FORECAST
EBIT Forecast Chart REVB
NET INCOME FORECAST
Net Income Chart REVB